Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?
Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space.
Medtronic Plc (MDT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 13,783,983 | $1,078,321,025 | +38% | 1.8% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 12,892,710 | $1,008,596,703 | +177% | 0.45% |
| 3. | Citadel Investment Group Ken Griffin | 5,373,877 | $420,398,397 | +447% | 0.05% |
| 4. | D E Shaw D. E. Shaw | 4,396,781 | $343,960,178 | +392% | 0.16% |
| 5. | AQR Capital Management Cliff Asness | 3,299,627 | $258,129,821 | +103% | 0.09% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $92.37 | 2,500 | $230,925.00 | 5,000 | 2025-08-25 | Filing | |
| $92.73 | 2,500 | $231,825.00 | 2,500 | 2025-08-22 | Filing | |
| $103.26 | 5,010 | $517,332.60 | 108,374 | 2021-12-16 | Filing | |
| $108.52 | 4,607 | $499,951.64 | 101,673 | 2020-10-08 | Filing | |
| $113.68 | 8,771 | $997,087.28 | 605,190 | 2020-02-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $83.15 | 3,102 | $257,931.30 | 35,694 | 2026-07-08 | Filing | |
| $80.45 | 228 | $18,342.60 | 37,227 | 2026-06-08 | Filing | |
| $80.44 | 3,961 | $318,622.84 | 37,455 | 2026-06-08 | Filing | |
| $97.82 | 385 | $37,660.70 | 32,768 | 2026-02-19 | Filing | |
| $97.83 | 668 | $65,347.10 | 33,153 | 2026-02-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 114,020,787 | $8,919,846,142 | 0.13% | |
| 2. | 83,816,735 | $6,556,983,180 | 0.14% | |
| 3. | 63,399,315 | $5,005,319,950 | 0.15% | |
| 4. | 34,059,967 | $2,664,511,218 | 0.12% | |
| 5. | 19,872,600 | $2,606,272,456 | 0.83% |
News See All
Johnson & Johnson vs. Medtronic: Which Healthcare Stock Is Better Positioned After Earnings?
Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year over year to $25.31 billion and surpassing analysts’ average estimate of around...
Is Medtronic (MDT) Becoming a Turnaround Story?
UBS upgraded Medtronic (NYSE:MDT) to a Buy from Neutral today, telling investors in a research note that a “turnaround” is underway at the company.
Intuitive Surgical (ISRG) vs. Medtronic (MDT): Which MedTech Stock Looks Better Positioned for Growth?
Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS reaching $...
10 Best Dividend Aristocrat Stocks To Buy Now
Global equity markets are on edge amid uncertainty in the Middle East, compounded by economic growth concerns.
Is Medtronic plc (MDT) A Good Stock To Buy Now?
Is MDT a good stock to buy? We came across a bullish thesis on Medtronic plc on TheDividendPrince’s Substack. In this article, we will summarize the bulls’ thesis on MDT.
10 Best Long Term Stocks to Buy According to Hedge Funds
On June 25, Allan Small, Senior Investment Advisor at Allan Small Financial Group, appeared on BNN Bloomberg to discuss investment opportunities and talk about the state of the market, which is trading...
10 Best Brain-Computer Interface Stocks to Buy
On May 10, Bloomberg reported that brain-computer interfaces are transitioning from experimental to early implementation, allowing users to control computers, robotic arms, and communication tools with...
Top 10 Stocks to Buy for Financial Stability
The Fed's updated quarterly projections showed nine officials now anticipate a hike by the end of 2026, a sharp reversal from the cuts previously expected, and markets responded by pricing in better-than...
10 Most Undervalued NYSE Stocks to Invest In
On June 8, Kim Iskyan, Director of Research at Tuttle Capital Management, appeared on BNN Bloomberg to discuss the outlook on the markets.
Hedge Fund Resource Center